School of Medicine
Showing 12,051-12,100 of 13,039 Results
-
Sui Wang, PhD
Associate Professor of Ophthalmology
On Leave from 2026-09-15 To 2026-12-15Current Research and Scholarly InterestsOur research focuses on unraveling the molecular mechanisms underlying retinal development and diseases. We employ genetic and genomic tools to explore how various retinal cell types, including neurons, glia, and the vasculature, respond to developmental cues and disease insults at the epigenomic and transcriptional levels. In addition, we investigate their interactions and collective contributions to maintain retinal integrity.
1. Investigating retinal development:
We utilize genetic tools and methods such as in vivo plasmid electroporation and CRISPR to dissect the roles of cis-regulatory elements and transcription factors in controlling retinal development.
2. Understanding diabetes-induced cell-type-specific responses in the retina:
Diabetes triggers a range of multicellular responses in the retina, such as vascular lesions, glial dysfunction, and neurodegeneration, all of which contribute to retinopathy. We delve into the detailed molecular mechanisms underlying these diabetes-induced cell-type-specific responses and the pathogenesis of diabetic retinopathy.
3. Developing molecular tools for labeling and manipulation of specific cell types in vivo:
Cis-regulatory elements, particularly enhancers, play pivotal roles in directing tissue- and cell-type-specific expression. Our interest lies in identifying enhancers that can drive cell type-specific expression in the retina and brain. We incorporate these enhancers into plasmid or AAV-based delivery systems, enabling precise labeling and manipulation of specific cell types in vivo. -
Taia T. Wang, MD, PhD, MSCI
Associate Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly InterestsLaboratory of Mechanisms in Human Immunity and Disease Pathogenesis
-
Tao Wang (王韬)
Director of Precision Diabetes Care, Genetics
Current Role at StanfordPrincipal Investigator, AI for Precision Diabetes Management
Project Manager & Scientific Co-lead, PsychENCODE Project
Project Initiator & Clinical Co-lead, Long COVID Clinical RCT with TCM
Project Initiator & Manager, AI & Wearables Toolkit for Biomedical Sciences
ENCODE and PsychENCODE Project Data Manager
Research Scientist, US Veteran Affairs Hospital
SCGPM HPC System Administrator -
Tong Wang
Instructor, Pathology
BioTong Wang, MD, PhD, is a physician-scientist in clinical pathology with interests in nucleic acid chemical biology, epigenetics, deep learning, useful tests, and novel therapeutics.
-
Tony Wang
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
BioTony Wang is a Clinical Assistant Professor in the Department of Anesthesiology, Perioperative, and Pain Medicine at Stanford University School of Medicine. He is a board-certified anesthesiologist and intensivist with clinical expertise in critical care medicine and liver transplant anesthesiology.
Dr. Wang completed his medical school training, anesthesiology residency, and critical care fellowship at the Johns Hopkins School of Medicine. Dr. Wang is deeply committed to medical education and academic innovation. He serves as the Associate Program Director for the Liver Transplant Anesthesiology Fellowship and is the founding director of Stanford's Anesthesiology Critical Care Education for Leaders (ACCEL) program. He is also Director of Residency Engagement for WikiAnesthesia, a comprehensive digital platform designed to serve as an open-access repository of anesthesia knowledge for trainees and practitioners.
Prior to medicine, Dr. Wang worked as a software engineer at Epic Systems, where he developed an appreciation for the intersection of technology and healthcare delivery.
His clinical interests include the perioperative management of complex patients, liver transplant anesthesiology, critical care medicine, and the integration of technology into anesthesiology education. -
Wenjun Wang
Postdoctoral Scholar, Stem Cell Transplantation
Current Research and Scholarly InterestsMy postdoctoral research focuses on investigating novel therapy for childhood leukemias.
-
Wenmin Wang
Postdoctoral Scholar, Ophthalmology
Current Research and Scholarly InterestsI am particularly interested in identifying therapeutic strategies for various eye disorders and investigating the mechanisms by which defects in inositol phosphatases lead to the disruption of primary cilia function and eye diseases by using Omics.
-
Xinnan Wang
Professor of Neurosurgery
Current Research and Scholarly InterestsMechanisms underlying mitochondrial dynamics and function, and their implications in neurological disorders.
-
Tauska
Affiliate, Genetics - BASE
BioI'm an ML engineer specializing in LLM post-training and agentic systems—with a particular focus on domains where rigor matters: health, biology, and scientific discovery.
Long-horizon agents — Designed and shipped multi-step orchestration systems (Pantheon-CLI, OmicVerse Agent) that outperform general SWE-agent baselines on biomedical tasks. Built cross-provider query routing and sandboxed execution to keep complex workflows robust over extended interactions. My agents don't just respond—they plan, recover from failure, and complete real research pipelines end-to-end.
Agentic science — Created infrastructure where AI doesn't assist research—it conducts it. Vectorized 30 years of NHANES data; parallelized Bayesian kernel machine regression on Kubernetes; built TCGA/GEO pipelines that bridge wet-lab and dry-lab workflows. Co-developed OmicVerse, an open-source platform powering reproducible multi-omics and single-cell analyses across hundreds of studies.
Experience engineering — Scaled rubric-based reward datasets to 1M+ pairs; trained summary and chain-of-thought reward models via RLAIF/RLHF; delivered measurable benchmark lifts in health AI. I care about the full loop: data curation → reward shaping → careful ablation → verifiable outcome—no cherry-picked demos—just metrics that survive scrutiny.
Currently pursuing advanced agentic studies at Karolinska Institutet and Stanford!
Open-source: OmicVerse · Pantheon-CLI · RAG Web UI · AstrBot
If you're working on post-training at scale, scientific agents, or high-integrity data pipelines—I'm always interested in systems that move from promising results to verifiable outcomes. Let's talk. -
Xunda Wang
Basic Life Res Scientist, Neurosurgery
Current Role at StanfordResearch Scientist
-
Yidan Wang
Postdoctoral Scholar, Neonatal and Developmental Medicine
BioI joined Dr. John Benjamin’s lab to study the heterogeneity of neutrophils across developmental stages and during bronchopulmonary dysplasia (BPD). My research focuses on characterizing neutrophil subsets and investigating the contributions of distinct neutrophil subsets to the development of BPD.
My predoctoral training was completed at Northwestern University under the co-mentorship of Dr. Harris Perlman and Dr. Deborah Winter. I studied the heterogeneity and functions of monocyte-lineage cells and macrophages in mouse synovial tissue under both steady-state and inflammatory arthritis conditions. -
Yiyu Wang
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
BioDr. Yiyu Wang is a T32 postdoctoral researcher at the Department of Anesthesiology, Stanford School of Medicine. Her research combines computational models and neuroimaging techniques to characterize the neural architecture underlying complex human experiences in emotion and pain. Her current work focuses on leveraging deep learning, foundation models, and explainable AI to improve neuroimaging-based markers as well as multi-modal markers of chronic pain.
-
Yunyun Wang
Postdoctoral Scholar, Cardiovascular Medicine
BioYunyun is a postdoctoral scholar in Cardiovascular Medicine at Stanford. She received her PhD in Genetics from Zhejiang University in China (2025), where she studied the metabolic-epigenetic mechanisms of cardiovascular disease such as atherosclerosis and angiogenesis. In 2026, she joined the Quertermous Lab, where her research focuses on uncovering the mechanisms underlying atherosclerosis using Perturb-seq technology.
-
Dr. Zhiyong Wang
Visiting Scholar, Genetics
BioDr. Wang is the acting director of the Department of Plant Biology, Carnegie Institution for Science, and a professor by courtesy of the Department of Biology, Stanford University. He is currently an associate editor of Molecular Cellular Proteomics, and editorial board member of Molecular Plant. He is a Fellow of the American Association for the Advancement of Science (AAAS) and recipient of the Humboldt Research Prize.
Dr. Wang obtained his Ph.D. in 1998 from UCLA, where he cloned the plant circadian clock gene CCA1. He did his postdoctoral research at the Salk Institute, where he studied the brassinosteroid signaling mechanism mediated by the BRI1 receptor kinase. Since joining Carnegie in 2001, his research has illustrated the receptor kinase signaling pathway that links the BRI1 receptor kinase to the BZR1 transcription factor and brassinosteroid-responsive genes in the Arabidopsis genome. He further demonstrated how the steroid signaling pathway integrates at the molecular level with other hormonal pathways, light signaling pathways, nutrient-sensing pathways, immunity pathways, and the circadian clock, to coordinately regulate plant growth and development. His lab uses combinations of genomic and proteomic approaches to understand how cellular signals are transduced and integrated through posttranslational modifications (e.g. phosphorylation and O-Glycosylation) and protein-protein interactions. His studies are elucidating the molecular mechanisms that control plant growth and mediate responses to environmental changes. -
Ziwei Wang
Postdoctoral Scholar, Radiation Therapy
Current Research and Scholarly InterestsMy current work focuses on establishing preclinical platforms to rapidly validate the functional impact of genetic alterations in tumors using both cell and genetically engineered mouse models. We hope this system can accelerate the discovery and translation of novel cancer therapies to patients.
-
Zongyi Wang
Postdoctoral Scholar, Psychiatry
Current Research and Scholarly InterestsSleep disruptions in neurodegenerative disorders
-
Irene Wapnir, MD
Professor of Surgery (General Surgery)
Current Research and Scholarly InterestsClinical trials in operative procedures such as Nipple-sparing mastectomy, arm lymphatic mapping, skin perfusion and Treatments for Breast Cancer, especially local recurrence. Dr. Wapnir is institutional Principal Investigator and Chair for National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials. Laboratory and translational research includes exploring the activity of breast iodide transporter in breast cancer brain metastasis.
-
(Alex) Alexandra Ward
Clinical Research Coordinator Associate, Pediatrics - Endocrinology
Bio(Alex) Alexandra Ward is a Clinical Research Coordinator in the Department of Pediatric Endocrinology at Stanford University School of Medicine. She works on a broad portfolio of clinical research studies focused on improving health outcomes for children and adolescents through patient-centered, technology-enabled, and equity-focused approaches. In her role, she coordinates industry-sponsored and investigator-initiated studies, oversees participant recruitment and study operations, manages regulatory compliance, and contributes to qualitative and quantitative data analysis, scientific writing, and dissemination of research findings.
Alexandra earned her Bachelor of Arts in Sociology with a focus on Pre-Medical Studies from the University of California, Berkeley. Her academic and research interests center on epidemiology, population health, and the social and structural factors that influence health across the lifespan. She is particularly interested in health equity, social determinants of health, implementation science, digital health technologies, aging, and the use of artificial intelligence to improve healthcare delivery and reduce disparities among underserved populations.
Her research experience spans pediatric endocrinology, chronic disease management, epidemiology, mixed-methods research, patient-reported outcomes, and community-engaged research. She has contributed to multiple peer-reviewed publications and scientific presentations and has collaborated on studies examining diabetes technology, healthcare access, quality of life, and interventions designed to improve health outcomes for diverse patient populations.
Alexandra plans to pursue a PhD in Epidemiology, where she hopes to develop innovative, data-driven approaches to address complex public health challenges and advance equitable healthcare through interdisciplinary research. -
Katherine T. Ward, MD
Clinical Professor, Medicine - Primary Care and Population Health
BioDr. Ward is the Chief of the Geriatrics Section in the Department of Medicine, Division of Primary Care and Population Health at Stanford University School of Medicine, and a Clinical Professor of Medicine. In this leadership role, she supervises program leaders across outpatient, inpatient, and skilled nursing facility settings, bringing them together to provide longitudinal, coordinated care to older adults across the healthcare continuum.
Dr. Ward is a fellowship-trained geriatrician with Stanford in Palo Alto, California, and is board certified in geriatric medicine, hospice and palliative medicine, and internal medicine. Her clinical practice spans all care settings—outpatient clinics, hospitals, and skilled nursing facilities—with a focus on managing the critical transitions between them. She specializes in comprehensive care for older adults, including dementia care, palliative care, geriatric assessment, and best practices in nursing home care. Dr. Ward draws on her extensive experience to teach and implement evidence based models that support care for older adults. Dr. Ward's research interests include early detection of dementia in vulnerable populations, dementia care support programs, and geriatric assessment in diverse populations.
She has published her research in peer-reviewed journals including the Journal of the American Geriatrics Society; The American Journal of Geriatric Pharmacotherapy; The Journal of Nutrition, Health & Aging; and the Journal of Palliative Medicine. She has served as an ad hoc reviewer for several journals, including Geriatrics, and has presented posters at annual meetings of the American Geriatrics Society and the Society of General Internal Medicine.
Dr. Ward is a member of the American College of Physicians and the American Geriatrics Society.